158 related articles for article (PubMed ID: 19632330)
1. Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo.
Endres K; Mitteregger G; Kojro E; Kretzschmar H; Fahrenholz F
Neurobiol Dis; 2009 Nov; 36(2):233-41. PubMed ID: 19632330
[TBL] [Abstract][Full Text] [Related]
2. Apparent reduction of ADAM10 in scrapie-infected cultured cells and in the brains of scrapie-infected rodents.
Chen C; Lv Y; Zhang BY; Zhang J; Shi Q; Wang J; Tian C; Gao C; Xiao K; Ren K; Zhou W; Dong XP
Mol Neurobiol; 2014 Dec; 50(3):875-87. PubMed ID: 24771043
[TBL] [Abstract][Full Text] [Related]
3. The effects of alpha-secretase ADAM10 on the proteolysis of neuregulin-1.
Freese C; Garratt AN; Fahrenholz F; Endres K
FEBS J; 2009 Mar; 276(6):1568-80. PubMed ID: 19220854
[TBL] [Abstract][Full Text] [Related]
4. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C
Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079
[TBL] [Abstract][Full Text] [Related]
5. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
Guo S; Peng M; Zhao Q; Zhang W
Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
[TBL] [Abstract][Full Text] [Related]
6. ADAM-10 over-expression increases cortical synaptogenesis.
Bell KF; Zheng L; Fahrenholz F; Cuello AC
Neurobiol Aging; 2008 Apr; 29(4):554-65. PubMed ID: 17187903
[TBL] [Abstract][Full Text] [Related]
7. The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex.
Jorissen E; Prox J; Bernreuther C; Weber S; Schwanbeck R; Serneels L; Snellinx A; Craessaerts K; Thathiah A; Tesseur I; Bartsch U; Weskamp G; Blobel CP; Glatzel M; De Strooper B; Saftig P
J Neurosci; 2010 Apr; 30(14):4833-44. PubMed ID: 20371803
[TBL] [Abstract][Full Text] [Related]
8. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
Taylor DR; Parkin ET; Cocklin SL; Ault JR; Ashcroft AE; Turner AJ; Hooper NM
J Biol Chem; 2009 Aug; 284(34):22590-600. PubMed ID: 19564338
[TBL] [Abstract][Full Text] [Related]
9. ADAM10 overexpression shifts lympho- and myelopoiesis by dysregulating site 2/site 3 cleavage products of Notch.
Gibb DR; Saleem SJ; Kang DJ; Subler MA; Conrad DH
J Immunol; 2011 Apr; 186(7):4244-52. PubMed ID: 21368228
[TBL] [Abstract][Full Text] [Related]
10. The cytoplasmic domain of a disintegrin and metalloproteinase 10 (ADAM10) regulates its constitutive activity but is dispensable for stimulated ADAM10-dependent shedding.
Maretzky T; Evers A; Le Gall S; Alabi RO; Speck N; Reiss K; Blobel CP
J Biol Chem; 2015 Mar; 290(12):7416-25. PubMed ID: 25605720
[TBL] [Abstract][Full Text] [Related]
11. ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function.
Suh J; Choi SH; Romano DM; Gannon MA; Lesinski AN; Kim DY; Tanzi RE
Neuron; 2013 Oct; 80(2):385-401. PubMed ID: 24055016
[TBL] [Abstract][Full Text] [Related]
12. The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity.
Cissé MA; Sunyach C; Lefranc-Jullien S; Postina R; Vincent B; Checler F
J Biol Chem; 2005 Dec; 280(49):40624-31. PubMed ID: 16236709
[TBL] [Abstract][Full Text] [Related]
13. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.
Schroeder A; Fahrenholz F; Schmitt U
J Alzheimers Dis; 2009; 16(2):309-14. PubMed ID: 19221420
[TBL] [Abstract][Full Text] [Related]
14. ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells.
Anderegg U; Eichenberg T; Parthaune T; Haiduk C; Saalbach A; Milkova L; Ludwig A; Grosche J; Averbeck M; Gebhardt C; Voelcker V; Sleeman JP; Simon JC
J Invest Dermatol; 2009 Jun; 129(6):1471-82. PubMed ID: 18971959
[TBL] [Abstract][Full Text] [Related]
15. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.
McDonald AJ; Dibble JP; Evans EG; Millhauser GL
J Biol Chem; 2014 Jan; 289(2):803-13. PubMed ID: 24247244
[TBL] [Abstract][Full Text] [Related]
16. Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17.
Deuss M; Reiss K; Hartmann D
Curr Alzheimer Res; 2008 Apr; 5(2):187-201. PubMed ID: 18393804
[TBL] [Abstract][Full Text] [Related]
17. Regulation of α-secretase ADAM10 expression and activity.
Endres K; Fahrenholz F
Exp Brain Res; 2012 Apr; 217(3-4):343-52. PubMed ID: 21969210
[TBL] [Abstract][Full Text] [Related]
18. A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10.
Parkin E; Harris B
J Neurochem; 2009 Mar; 108(6):1464-79. PubMed ID: 19183255
[TBL] [Abstract][Full Text] [Related]
19. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the alpha-secretase ADAM10--risk or reason for hope?
Endres K; Fahrenholz F
FEBS J; 2010 Apr; 277(7):1585-96. PubMed ID: 20136654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
